This year will be one of "transition" for GSK because of significant patent expirations -- of Coreg, Lamictal, Requip and Imitrex -- and safety-related ...
On the up side, turnover of Seretide/Advair (salmeterol/fluticasone propionate) for asthma jumped 10% to £3.5 billion; Lamictal (lamotrigine), ...
A spokeswoman for GlaxoSmithKline, Mary Anne Rhyne, said its analysis of clinical trials of Lamictal found “general trends that were similar to those seen ...
all 82 news articles
Glaxo faces at least six major drugs losing patent protection this year, including its Coreg heart medication, Lamictal epilepsy treatment and Requip ...
The drugs include Topamax by Johnson & Johnson and Lamictal by GlaxoSmithKline PLC. Some of the drugs are also approved to treat migraines and certain pain ...
A patient incorrectly received bipolar drug Lamictal instead of blood pressure drug Labetalol. A few days later, the patient was hospitalized with elevated ...
Quite a few prescription medications are spelt and sound similar such as the anti epileptic drug Lamictal and the anti fungal drug Lamisil. ...
In 2008, Teva is expected to launch generic versions of three major blockbuster drugs namely Fosamax for osteoporosis ($1.9 million), Lamictal ($1.9 ...
Lamotrigine Tablets are the generic version of GlaxoSmithKline's Lamictal(R) Tablets, which had US sales of approximately $1.97 million for the 12 months ...